Interferon alfa-2b Injection Shortage
Last Updated: January 10, 2022
Status: Current
Products Affected - Description
-
- Intron A injection, Merck, 10 million units, vial, 1 count, NDC 00085-4350-01
- Intron A injection, Merck, 18 million units, vial, 1 count, NDC 00085-4351-01
- Intron A injection, Merck, 50 million units, vial, 1 count, NDC 00085-4352-01
- Intron A injection, Merck, 10 million units/mL, 2.5 mL vial, 1 count, NDC 00085-1133-01
- Intron A injection, Merck, 6 million units/mL, 3 mL vial, 1 count, NDC 00085-1168-01
Reason for the Shortage
-
- Merck has made a business decision to discontinue all presentations of Intron A.
- They are the sole suppliers of interferon alfa-2b.
Available Products
-
- There is insufficient supply for usual ordering
Estimated Resupply Dates
-
- Merck has discontinued all presentations of Intron A solution for injection.
- Merck has discontinued all presentations of Intron A powder for injection.
Updated
Updated January 10, 2022 by Michelle Wheeler, PharmD, Drug Information Specialist. Created March 30, 2021 by Michelle Wheeler, PharmD, Drug Information Specialist. © 2022, Drug Information Service, University of Utah, Salt Lake City, UT.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.